Canaccord raised the firm’s price target on Aspen Aerogels to $28 from $18 and keeps a Buy rating on the shares. The firm said the results showed good revenue momentum, profitability and a guidance bump and they estimate Aspen has significantly better growth prospects than the median of its peers.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels Projects Financial Outlook for 2024
- Aspen Aerogels raises FY24 EPS view to greater than 3c from greater than (30c)
- Aspen Aerogels, Inc. Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Aspen Aerogels reports Q1 EPS (2c), consensus (11c)
- Aspen Aerogels options imply 11.0% move in share price post-earnings